A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants
Clinical trial NCT00192348 · COMPLETED
Trial details
- NCT number
- NCT00192348
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.